Patents by Inventor Manju Ray

Manju Ray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained Release Formulations Containing Methylglyoxal and Their Therapeutic Applications
    Publication number: 20160243056
    Abstract: Provided herein is a nano drug composition for the treatment of cancer including 0.125-0.5 mg of methylglyoxal as conjugated to nanoparticles of chitosan, its derivatives, or other polymers; 25-100 mg of ascorbic acid; 75-300 mg of creatine; and 0.125-0.5 mg of melatonin, wherein all constituents are meant for each kg of body weight.
    Type: Application
    Filed: October 1, 2013
    Publication date: August 25, 2016
    Inventors: MANJU RAY, JITENDRA NATH VERMA, LILY VERMA
  • In vivo assessment of toxicity and pharmacokinetics of methylglyoxal
    Patent number: 9198896
    Abstract: A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: December 1, 2015
    Assignee: NATIONAL RESEARCH DEVELOPMENT CORPORATION
    Inventor: Manju Ray
  • IN VIVO ASSESSMENT OF TOXICITY AND PHARMACOKINETICS OF METHYLGLYOXAL
    Publication number: 20110118327
    Abstract: A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin.
    Type: Application
    Filed: August 18, 2010
    Publication date: May 19, 2011
    Inventor: Manju Ray
  • In vivo assessment of toxicity and pharmacokinetics of methylglyoxal
    Publication number: 20080188541
    Abstract: A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin.
    Type: Application
    Filed: August 21, 2007
    Publication date: August 7, 2008
    Inventor: Manju Ray
  • Anticancer activity of imino acid conjugates or methylglyoxal
    Patent number: 6613793
    Abstract: The invention relates to the use of imino acid conjugates of methylglyoxal for the inhibition and/or treatment of cancer. The invention relates more specifically to the use imino acid conjugates of methylglyoxal for inhibition and/or treatment of cancer of the Colon, Prostate, Larynx, Kidney, Pancreas, Lung, Breast, Intestine, Oral cavity, Ovary, Glioblastoma, and Leukemia. The invention also relates to compositions and methods of inhibiting cancer using imino acid conjugates of methylglyoxal.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: September 2, 2003
    Assignee: Dabur Research Foundation
    Inventors: Anand C. Burman, Rama Mukherjee, Manu Jaggi, Anu T. Singh, Kamal K. Kapoor, Sudhanand Prasad, Manju Ray
  • Anticancer activity of imino acid conjugates of methylglyoxal
    Publication number: 20030118627
    Abstract: The invention relates to the use of imino acid conjugates of methylglyoxal for the inhibition and/or treatment of cancer. The invention relates more specifically to the use imino acid conjugates of methylglyoxal for inhibition and/or treatment of cancer of the Colon, Prostate, Larynx, Kidney, Pancreas, Lung, Breast, Intestine, Oral cavity, Ovary, Glioblastoma, and Leukemia. The invention also relates to compositions and methods of inhibiting cancer using imino acid conjugates of methylglyoxal.
    Type: Application
    Filed: July 1, 2002
    Publication date: June 26, 2003
    Applicant: DABUR RESEARCH FOUNDATION
    Inventors: Anand C. Burman, Rama Mukherjee, Manu Jaggi, Anu T. Singh, Kamal K. Kapoor, Sudhanand Prasad, Manju Ray